PRVA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
632.6M
+4.8%
603.8M
+11.6%
541.2M
-6.8%
580.4M
+11.4%
521.2M
Cost of Revenue
69.4M
+1.4%
68.4M
+2.4%
66.8M
+8.8%
61.4M
-5.4%
64.9M
Gross Profit
563.3M
+5.2%
535.4M
+12.9%
474.3M
-8.6%
519.0M
+13.8%
456.2M
Operating Expenses
51.0M
-3.5%
52.9M
+37.8%
38.4M
-22.3%
49.4M
+5.2%
46.9M
R&D
0
0
0
0
0
SG&A
47.7M
-3.9%
49.6M
+38.9%
35.7M
-23.3%
46.6M
+5.1%
44.3M
Operating Income
512.3M
+6.2%
482.5M
+10.7%
435.9M
-7.2%
469.6M
+14.7%
409.3M
EBITDA
515.6M
+6.1%
485.8M
+10.8%
438.6M
-7.1%
472.4M
+14.7%
411.9M
Net Income
9.7M
+162.4%
3.7M
-65.0%
10.6M
+7.9%
9.8M
+198.3%
3.3M
EPS (Basic)
$0.07
+250.0%
$0.02
-71.4%
$0.07
+16.7%
$0.06
+200.0%
$0.02
EPS (Diluted)
$0.07
+250.0%
$0.02
-71.4%
$0.07
+40.0%
$0.05
+150.0%
$0.02
Shares (Diluted)
131.8M
+0.7%
130.9M
+0.2%
130.6M
+1.4%
128.8M
+0.3%
128.4M
Privia Health (PRVA) โ€” Financials